PMID- 35702824 OWN - NLM STAT- MEDLINE DCOM- 20220908 LR - 20230606 IS - 1098-2272 (Electronic) IS - 0741-0395 (Print) IS - 0741-0395 (Linking) VI - 46 IP - 7 DP - 2022 Oct TI - Novel HLA associations with outcomes of Mycobacterium tuberculosis exposure and sarcoidosis in individuals of African ancestry using nearest-neighbor feature selection. PG - 463-474 LID - 10.1002/gepi.22490 [doi] AB - Tuberculosis and sarcoidosis are inflammatory diseases characterized by granulomas that may occur in any organ but are often found in the lung. The panoply of classical human leukocyte antigen (HLA) alleles associated with occurrence and/or severity of both diseases varies considerably across studies. This heterogeneity of results, due to variation in factors like ancestry and disease subphenotype, as well as the use of simple modeling strategies to elucidate likely complex relationships, has made conclusions about underlying commonalities difficult. Here we perform HLA association analyses in individuals of African ancestry, using a greater resolution to include subphenotypes of disease and employing more comprehensive analytical techniques. Using a novel application of nearest-neighbor feature selection to score allelic importance, we investigated HLA allele association with Mycobacterium tuberculosis exposure outcomes in the first analysis of both latent Mycobacterium tuberculosis infection and active disease compared with those who, despite long-term exposure to active index cases, have neither positive diagnostic tests nor display clinical symptoms. We also compared persistent to resolved sarcoidosis. This led to the identification of novel HLA associations and evidence of main effects and interaction effects. We found strikingly similar main effects and interaction effects at HLA-DRB1, -DQB1, and -DPB1 in those resistant to tuberculosis (either latent or active) and persistent sarcoidosis. CI - (c) 2022 Wiley Periodicals LLC. FAU - Dawkins, Bryan A AU - Dawkins BA AUID- ORCID: 0000-0003-0087-312X AD - Department of Genes and Human Disease, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA. FAU - Garman, Lori AU - Garman L AD - Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA. FAU - Cejda, Nicholas AU - Cejda N AD - Department of Genes and Human Disease, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA. FAU - Pezant, Nathan AU - Pezant N AD - Department of Genes and Human Disease, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA. FAU - Rasmussen, Astrid AU - Rasmussen A AUID- ORCID: 0000-0001-7744-2948 AD - Department of Genes and Human Disease, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA. FAU - Rybicki, Benjamin A AU - Rybicki BA AUID- ORCID: 0000-0003-3190-3467 AD - Department of Public Health Sciences, Henry Ford Health System, Detroit, Michigan, USA. FAU - Levin, Albert M AU - Levin AM AD - Department of Public Health Sciences, Henry Ford Health System, Detroit, Michigan, USA. AD - Center for Bioinformatics, Henry Ford Health System, Detroit, Michigan, USA. FAU - Benchek, Penelope AU - Benchek P AD - Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, Ohio, USA. FAU - Seshadri, Chetan AU - Seshadri C AD - Department of Medicine, University of Washington, Seattle, Washington, USA. FAU - Mayanja-Kizza, Harriet AU - Mayanja-Kizza H AD - Department of Medicine, Makerere University and Mulago Hospital, Kampala, Uganda. FAU - Iannuzzi, Michael C AU - Iannuzzi MC AD - Department of Public Health Sciences, Henry Ford Health System, Detroit, Michigan, USA. FAU - Stein, Catherine M AU - Stein CM AD - Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, Ohio, USA. AD - Division of Infectious Diseases and HIV Medicine, Department of Medicine, Case Western Reserve University, Cleveland, Ohio, USA. FAU - Montgomery, Courtney G AU - Montgomery CG AD - Department of Genes and Human Disease, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA. LA - eng GR - U54 GM104938/GM/NIGMS NIH HHS/United States GR - P30 GM110766/GM/NIGMS NIH HHS/United States GR - R01 HL113326/HL/NHLBI NIH HHS/United States GR - R33 AI138272/AI/NIAID NIH HHS/United States GR - T32 AI007633/AI/NIAID NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20220614 PL - United States TA - Genet Epidemiol JT - Genetic epidemiology JID - 8411723 RN - 0 (HLA-DRB1 Chains) SB - IM MH - Alleles MH - Gene Frequency MH - Genetic Predisposition to Disease MH - HLA-DRB1 Chains/genetics MH - Humans MH - *Mycobacterium tuberculosis/genetics MH - *Sarcoidosis/genetics MH - *Tuberculosis/genetics PMC - PMC10237150 MID - NIHMS1903979 OTO - NOTNLM OT - HLA OT - Mycobacterium tuberculosis OT - epistasis OT - nearest-neighbor feature selection OT - resistance to infection OT - sarcoidosis COIS- Disclosures: The research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The authors alone are responsible for the content and writing of the paper. EDAT- 2022/06/16 06:00 MHDA- 2022/09/09 06:00 PMCR- 2023/06/02 CRDT- 2022/06/15 02:53 PHST- 2022/05/20 00:00 [revised] PHST- 2022/01/31 00:00 [received] PHST- 2022/05/25 00:00 [accepted] PHST- 2022/06/16 06:00 [pubmed] PHST- 2022/09/09 06:00 [medline] PHST- 2022/06/15 02:53 [entrez] PHST- 2023/06/02 00:00 [pmc-release] AID - 10.1002/gepi.22490 [doi] PST - ppublish SO - Genet Epidemiol. 2022 Oct;46(7):463-474. doi: 10.1002/gepi.22490. Epub 2022 Jun 14.